"Novel Antidepressant Enhances Cancer-Fighting Capacity"

A new study from China suggests that the antidepressant ansofaxine hydrochloride, already approved for treating major depressive disorder, may also enhance the body's ability to fight certain types of cancer when combined with anti-tumor drugs. In experiments with mice, the drug showed promise in inhibiting colon cancer cell growth, strengthening the immune system, and inducing programmed cell death. While the results are promising, further research is needed to determine its effectiveness in human cancer treatment. Other antidepressants like fluoxetine and sertraline have also shown potential in combination with anti-cancer drugs, but more rigorous studies are required to confirm their efficacy.